Xencor Inc SEC filings XNCR
Xencor Inc has 897 filings in SEC EDGAR's recent list, going back to May 6, 2005. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFR14A | Filing | May 1, 2023 | — |
| D | Filing | Nov 19, 2021 | — |
| SEC STAFF LETTER | Filing | Sep 27, 2019 | — |
| SEC STAFF LETTER | Filing | Sep 17, 2019 | — |
| CT ORDER | Filing | Jul 24, 2019 | — |
| CT ORDER | Filing | Jul 24, 2019 | — |
| CT ORDER | Filing | Jul 24, 2019 | — |
| CT ORDER | Filing | Oct 26, 2018 | — |
| UPLOAD | Letter from the SEC | Sep 21, 2017 | — |
| CORRESP | Letter to the SEC | Aug 30, 2017 | — |
| UPLOAD | Letter from the SEC | Aug 10, 2017 | — |
| CORRESP | Letter to the SEC | Aug 3, 2017 | — |
| UPLOAD | Letter from the SEC | Jul 11, 2017 | — |
| CORRESP | Letter to the SEC | Jun 22, 2017 | — |
| UPLOAD | Letter from the SEC | Jun 22, 2017 | — |
| CT ORDER | Filing | Nov 18, 2016 | — |
| EFFECT | Filing | Oct 5, 2016 | — |
| CORRESP | Letter to the SEC | Oct 3, 2016 | — |
| UPLOAD | Letter from the SEC | Sep 29, 2016 | — |
| CT ORDER | Filing | Sep 26, 2016 | — |
| CT ORDER | Filing | Sep 20, 2016 | — |
| CT ORDER | Filing | Dec 17, 2015 | — |
| CT ORDER | Filing | Dec 17, 2015 | — |
| EFFECT | Filing | Jan 23, 2015 | — |
| CT ORDER | Filing | Dec 4, 2013 | — |
| EFFECT | Filing | Dec 2, 2013 | — |
| CORRESP | Letter to the SEC | Nov 27, 2013 | — |
| CORRESP | Letter to the SEC | Nov 27, 2013 | — |
| CERTNAS | Auto-generated paper document | Nov 8, 2013 | — |
| CORRESP | Letter to the SEC | Nov 8, 2013 | — |
| CORRESP | Letter to the SEC | Nov 8, 2013 | — |
| 8-A12B | Filing | Nov 7, 2013 | — |
| CORRESP | Letter to the SEC | Oct 28, 2013 | — |
| CORRESP | Letter to the SEC | Oct 25, 2013 | — |
| UPLOAD | Letter from the SEC | Oct 24, 2013 | — |
| CORRESP | Letter to the SEC | Oct 11, 2013 | — |
| UPLOAD | Letter from the SEC | Oct 8, 2013 | — |
| DRSLTR | Filing | Sep 11, 2013 | — |
| DRS | Filing | Sep 11, 2013 | — |
| D | Filing | Jul 1, 2013 | — |
| D | Filing | Dec 27, 2010 | — |
| D | Filing | Apr 10, 2009 | — |
| REGDEX | Auto-generated paper document | Aug 1, 2006 | — |
| REGDEX | Auto-generated paper document | May 6, 2005 | — |
Showing 44 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- XNCR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Pasadena, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1326732
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.